Insider Trading Arrangements	9 Months Ended
Sep. 30, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	A written plan entered into by Evan Bakst, a Director of the Company, on May 23, 2023 for the sale of an aggregate 8,700 shares of common stock terminated in accordance with the plan term on September 15, 2023. The plan was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. On September 14, 2023, David P. Sponsel, the Company's Executive Vice President, Sales, entered into a written plan for the sale of up to 104,680 shares of common stock. The number of shares of common stock to potentially be sold pursuant to this written plan will depend on the terms of current unvested equity compensation awards granted to Mr. Sponsel and the Company’s achievement relative to applicable performance measures for such current unvested equity compensation awards. In addition, the actual number of shares that will be released to Mr. Sponsel in connection with these awards and sold under Rule 10b5-1(c) will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and is scheduled to terminate no later than November 29, 2024. On September 11, 2023, Craig E. Hunsaker, the Company's Executive Vice President, People and Culture, entered into a written plan for the sale of shares of common stock. The number of shares of common stock to potentially be sold pursuant to this written plan is intended to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and is scheduled to terminate no later than March 28, 2024. On August 10, 2023, Scott Lish, the Company's Senior Vice President, Research & Development, modified a written plan for the sale of up to 97,585 shares of common stock. The number of shares of common stock to potentially be sold pursuant to this written plan will depend on the terms of current unvested equity compensation awards granted to Mr. Lish and the Company’s achievement relative to applicable performance measures for such current unvested equity compensation awards. In addition, the actual number of shares that will be released to Mr. Lish in connection with these awards and sold under Rule 10b5-1(c) will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and is scheduled to terminate no later than March 7, 2025. On August 10, 2023, Beth Altman, a Director of the Company, terminated a written plan for the sale of an aggregate 12,742 shares of common stock. The plan was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Evan Bakst
Trading Arrangements, by Individual
Name	Evan Bakst
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 23, 2023
Termination Date	September 15, 2023
Aggregate Available	8,700
David P. Sponsel
Trading Arrangements, by Individual
Name	David P. Sponsel
Title	Executive Vice President
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 14, 2023
Termination Date	November 29, 2024
Aggregate Available	104,680
Craig E. Hunsaker
Trading Arrangements, by Individual
Name	Craig E. Hunsaker
Title	Executive Vice President
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 11, 2023
Termination Date	March 28, 2024
Scott Lish
Trading Arrangements, by Individual
Name	Scott Lish
Title	Senior Vice President
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 10, 2023
Termination Date	March 7, 2025
Aggregate Available	97,585
Beth Altman
Trading Arrangements, by Individual
Name	Beth Altman
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Termination Date	August 10, 2023
Aggregate Available	12,742

Insider Trading Arrangements

9 Months Ended

Sep. 30, 2023

A written plan entered into by Evan Bakst, a Director of the Company, on May 23, 2023 for the sale of an aggregate 8,700 shares of common stock terminated in accordance with the plan term on September 15, 2023. The plan was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

On September 14, 2023, David P. Sponsel, the Company's Executive Vice President, Sales, entered into a written plan for the sale of up to 104,680 shares of common stock. The number of shares of common stock to potentially be sold pursuant to this written plan will depend on the terms of current unvested equity compensation awards granted to Mr. Sponsel and the Company’s achievement relative to applicable performance measures for such current unvested equity compensation awards. In addition, the actual number of shares that will be released to Mr. Sponsel in connection with these awards and sold under Rule 10b5-1(c) will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and is scheduled to terminate no later than November 29, 2024.

On September 11, 2023, Craig E. Hunsaker, the Company's Executive Vice President, People and Culture, entered into a written plan for the sale of shares of common stock. The number of shares of common stock to potentially be sold pursuant to this written plan is intended to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and is scheduled to terminate no later than March 28, 2024.

On August 10, 2023, Scott Lish, the Company's Senior Vice President, Research & Development, modified a written plan for the sale of up to 97,585 shares of common stock. The number of shares of common stock to potentially be sold pursuant to this written plan will depend on the terms of current unvested equity compensation awards granted to Mr. Lish and the Company’s achievement relative to applicable performance measures for such current unvested equity compensation awards. In addition, the actual number of shares that will be released to Mr. Lish in connection with these awards and sold under Rule 10b5-1(c) will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and is scheduled to terminate no later than March 7, 2025.

On August 10, 2023, Beth Altman, a Director of the Company, terminated a written plan for the sale of an aggregate 12,742 shares of common stock. The plan was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Evan Bakst

Trading Arrangements, by Individual

Name

Evan Bakst

Title

Director

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

May 23, 2023

Termination Date

September 15, 2023